tiprankstipranks
Trending News
More News >
Basilea Pharmaceutica (CH:BSLN)
:BSLN
Switzerland Market

Basilea Pharmaceutica (BSLN) Income Statement

Compare
0 Followers

Basilea Pharmaceutica Income Statement

Last quarter (Q4 2024), Basilea Pharmaceutica's total revenue was CHF132.25M, an increase of 48.40% from the same quarter last year. In Q4, Basilea Pharmaceutica's net income was CHF56.86M. See Basilea Pharmaceutica’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
CHF 208.54MCHF 157.63MCHF 147.76MCHF 148.12MCHF 127.63M
Gross Profit
CHF 92.72MCHF 130.84MCHF 120.96MCHF 124.05MCHF 103.58M
Operating Expenses
CHF 31.54MCHF 111.64MCHF 104.62MCHF 122.88MCHF 126.83M
Depreciation and Amortization
CHF 1.43MCHF 1.58MCHF 3.10MCHF 2.45MCHF 2.29M
EBITDA
CHF 63.13MCHF 23.18MCHF 26.21MCHF 6.72MCHF -2.24M
Operating Income
CHF 61.18MCHF 19.20MCHF 16.34MCHF 1.17MCHF -23.26M
Other Income/Expenses
CHF -917.00KCHF -8.74MCHF -6.44MCHF -7.98MCHF -6.45M
Pretax Income
CHF 60.26MCHF 10.46MCHF 12.10MCHF -6.79MCHF -14.67M
Net Income
CHF 77.59MCHF 10.45MCHF 12.15MCHF -6.83MCHF -14.72M
Per Share Metrics
Basic EPS
CHF 5.82CHF 0.87CHF 1.02CHF -0.58CHF -1.43
Diluted EPS
CHF 5.60CHF 0.86CHF 1.02CHF -0.58CHF -1.43
Weighted Average Shares Outstanding
13.32M 11.99M 11.86M 11.68M 10.28M
Weighted Average Shares Outstanding (Diluted)
13.86M 12.14M 11.94M 11.68M 10.28M
Currency in CHF

Basilea Pharmaceutica Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis